Amundi’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $699K | Buy |
39,091
+39,041
| +78,082% | +$698K | ﹤0.01% | 1287 |
|
|
2025
Q1 | $849 | Sell |
50
-9
| -15% | -$153 | ﹤0.01% | 2051 |
|
|
2024
Q4 | $1.71K | Buy |
+59
| New | +$1.71K | ﹤0.01% | 1994 |
|
|
2024
Q1 | – | Sell |
-60,000
| Closed | -$884K | – | 2041 |
|
|
2023
Q4 | $884K | Buy |
+60,000
| New | +$884K | ﹤0.01% | 1347 |
|
|
2023
Q3 | – | Sell |
-81,944
| Closed | -$3.47M | – | 2042 |
|
|
2023
Q2 | $3.47M | Sell |
81,944
-140,754
| -63% | -$5.96M | ﹤0.01% | 1053 |
|
|
2023
Q1 | $13.8M | Buy |
222,698
+18,929
| +9% | +$1.18M | 0.01% | 771 |
|
|
2022
Q4 | $19.7M | Buy |
203,769
+19,184
| +10% | +$1.86M | 0.01% | 698 |
|
|
2022
Q3 | $15.7M | Buy |
184,585
+23,618
| +15% | +$2.01M | 0.01% | 742 |
|
|
2022
Q2 | $11.7M | Buy |
160,967
+79,567
| +98% | +$5.8M | 0.01% | 738 |
|
|
2022
Q1 | $7M | Buy |
81,400
+9,528
| +13% | +$820K | ﹤0.01% | 896 |
|
|
2021
Q4 | $5.01M | Buy |
71,872
+2,842
| +4% | +$198K | ﹤0.01% | 996 |
|
|
2021
Q3 | $8.02M | Buy |
69,030
+11,940
| +21% | +$1.39M | 0.01% | 891 |
|
|
2021
Q2 | $12.7M | Buy |
+57,090
| New | +$12.7M | 0.01% | 780 |
|